Lgr4tm2.1Npa
Targeted Allele Detail
|
|
| Symbol: |
Lgr4tm2.1Npa |
| Name: |
leucine-rich repeat-containing G protein-coupled receptor 4; targeted mutation 2.1, Novartis Pharma AG |
| MGI ID: |
MGI:6724064 |
| Synonyms: |
Lgr4lox, LGR4tm1Npa |
| Gene: |
Lgr4 Location: Chr2:109747992-109844602 bp, + strand Genetic Position: Chr2, 56.65 cM
|
| Alliance: |
Lgr4tm2.1Npa page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:236636
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
C57BL/6
|
|
| Allele Type: |
|
Targeted (Conditional ready, No functional change) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A loxP site was inserted upstream of exon 1 and a second loxP site into intron 1. The loxP sites are approximately 1.9 kb apart and flank the start codon-containing first exon. The FRT site flanked neomycin resistance gene cassette that was also inserted, was removed through subsequent flp-mediated recombination.
(J:236636)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Lgr4 Mutation: |
92 strains or lines available
|
|
| Original: |
J:236636 Planas-Paz L, et al., The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. Nat Cell Biol. 2016 May;18(5):467-79 |
| All: |
1 reference(s) |
|